Skip to main
G
G logo

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 17 analyst ratings
Hold
Strong Buy 18%
Buy 18%
Hold 53%
Sell 6%
Strong Sell 6%

Bulls say

Genpact Ltd has demonstrated strong growth in key sectors, with Hi-tech, manufacturing, and services revenue increasing by 9.1% year-over-year, fueled by heightened spending from existing clients, particularly in AI and data analytics. The digital operations segment also showed resilience, with revenues growing 6.1% year-over-year on a constant currency basis, indicating robust demand for Genpact's business process management solutions as corporations focus on achieving operational efficiencies. Additionally, a 2.8% sequential increase in headcount reflects Genpact's commitment to scaling operations in response to a steady flow of new business wins and sustained demand for analytics and data solutions.

Bears say

Genpact Ltd faces a negative outlook primarily due to persistent employee retention issues in key regions, which may hinder its revenue growth prospects. Furthermore, macroeconomic shocks, such as those experienced during the Covid-19 pandemic, could exacerbate slow client decision-making processes, further impacting revenue generation. Lastly, unfavorable currency fluctuations pose an additional risk, potentially affecting both top-line and bottom-line performance.

Genpact (G) has been analyzed by 17 analysts, with a consensus rating of Hold. 18% of analysts recommend a Strong Buy, 18% recommend Buy, 53% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Hold based on their latest research and market trends.

According to 17 analysts, Genpact (G) has a Hold consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $40.24, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $40.24, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.